Understanding vitamin D beyond the basics
The research collection
Library
Start with your question
Search the Library
Ask a question in your own words, or look for a particular study.
Need an idea? Try one of these.
Or browse the Library collections below ↓At a Glance
Just want the results or the conclusion?
Open At a Glance on a Library study page for a menu of questions drawn from that paper. Choose Results to see what the researchers found, or Conclusion to read what they think those findings mean.
Find a study
Search above or browse a collection below. Open a paper that interests you.
Choose what to read
Tap a heading in the At a Glance menu to open its answer. Tap it again to close it.
Explore further
Follow the source link to read the passage in context, or use Related reading to find another study.
Try At a Glance in a study
New to the Library?
Start with an abstract for the authors’ short account, or open a full paper to read the study in detail.
Choose your collection
Working demo. The full Library is being prepared.
Full papers
Read the complete studies.
Abstracts
Read the authors’ study abstracts.
Archived full papers
Full papers in the archive.
In preparation
Archived abstracts
Study abstracts in the archive.
In preparation
Secondary full papers
Full papers with secondary relevance to vitamin D.
Secondary abstracts
Abstracts with secondary relevance to vitamin D.
Matching papers
Abstract · 2025
Perirenal fat differs in patients with chronic kidney disease receiving different vitamin D-based treatments: a preliminary study
From the paper Chronic kidney disease (CKD) patients show high rates of cardiovascular disease (CVD) and mortality. In the general population, obesity, hypertension, and diabetes are known as the classical CVD risk factors. However, CKD patients have other predisposing CVD factors more associated with bone and…
Heart, circulation and kidneys
Abstract · 2021
Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease
From the paper We evaluated 2445 CKD patients (2010 to 2012). The information collected was: clinical, anthropometric and analytical parameters, treatments and CVD evaluation (intima-media thickness (IMT), atheromatous plaque presence and ankle-brachial index (ABI)). Laboratory, vital status, CVE and hospitalizations were collected for 4 years.
Heart, circulation and kidneys
Abstract · 2022
Coronary artery calcification in patients with advanced chronic kidney disease
From the paper Serum calcium levels were positively correlated with N-MID, P1NP, β-CTx, and iPTH (r = 0.19, r = 0.24, r = 0.21, r = 0.21, respectively), and serum phosphorus levels were positively correlated with N-MID, P1NP, β-CTx, and iPTH (r = 0.50, r =…
Heart, circulation and kidneys
Abstract · 2015
Effect of Paricalcitol vs Calcitriol on Hemoglobin Levels in Chronic Kidney Disease Patients: A Randomized Trial
From the paper In this randomized trial 60 CKD patients stage 3b-5 and anemia (Hb levels: 10-12.5 g/dL) were assigned (1:1) to receive low doses of calcitriol (Group Calcitriol) or paricalcitol (Group Paricalcitol) for 6 months. All the patients had normal values of plasma calcium, phosphorus…
Heart, circulation and kidneys
Abstract · 2017
Effects of the Administration of 25(OH) Vitamin D3 in an Experimental Model of Chronic Kidney Disease in Animals Null for 1-Alpha-Hydroxylase
From the paper The final step in vitamin D activation is catalyzed by 1-alpha-hydroxylase (CYP27B1). Chronic kidney disease (CKD) is characterized by low levels of both 25(OH)D3 and 1,25(OH)2D3 provoking secondary hyperparathyroidism (2HPT). Therefore, treatments with active or native vitamin D compounds are common in CKD…
Heart, circulation and kidneys
Abstract · 2017
Vitamin D and methylarginines in chronic kidney disease (CKD)
From the paper Paricalcitol produced the expected small rise in serum calcium and phosphate and a marked PTH suppression. However, ADMA [Paricalcitol: baseline 0.75 μMol/L (95%CI: 0.70 to 0.81), 12 week 0.72 μMol/L (95%CI: 0.66 to 0.78); Placebo: baseline 0.75 μMol/L (95%CI: 0.70 to 0.90) 12 weeks 0.70 μMol/L (95%CI: 0.66 to 0.74)] and…
Heart, circulation and kidneys
Abstract · 2024
Fragility Fractures in End-Stage Chronic Kidney Disease (CKD) Population: Patient-Related and CKD-Related Factor Analysis: A Single-Center Experience
Bones and muscles
Abstract · 2025
Clinical Safety and Efficacy of Allogeneic Adipose Stem Cells: A Systematic Review of the Clinical Trials
From the paper Our review was strictly limited to the inclusion of controlled clinical trials to ensure the relevance and quality of the data. After screening, 22 articles were retained, with a total of 953 patients that met the established inclusion criteria. The data obtained from…
Metabolism and blood sugar
Full papers
Working demo.
Abstracts
Working demo.
Archived full papers
This collection is being prepared.
Archived abstracts
This collection is being prepared.
Related reading
Vitamin D: What It Is
Learn what vitamin D is, how it functions as a regulatory molecule, and why activation, signalling, and biological context matter more than simple measurements.
Read more →